Form D — ZETAGEN THERAPEUTICS, INC.
0001730728-25-000001 · filed 2025-01-23
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $6,173,828
- Total sold
- $83,186
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ZETAGEN THERAPEUTICS, INC.
- CIK
- 1730728
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 841 EAST FAYETTE STREET
SYRACUSE, NY 13210 - Phone
- 401-699-9402
Related persons
-
Nikhil Thakur, MD · Executive OfficerAndover, MA
-
Peter B. Finn · Executive OfficerBoston, MA
-
Joe C Loy · Executive OfficerWeatherford, TX
-
Donald Brown · DirectorHopkinton, MA
-
Ashok Kaveeshwar · DirectorBethesda, MD
-
Richard Warburg · DirectorBethesda, MD
View original on SEC EDGAR.